Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katsumi, Terasita"'
Autor:
Yoshihito Uchida, Yoshiya Yamamoto, Masatsugu Ohara, Yoshiyuki Ueno, Katsumi Terasita, Chitomi Hasebe, Naoya Sakamoto, Koji Ogawa, Naoki Kawagishi, Jun Inoue, Yoko Tsukuda, Masaru Baba, Tomoe Kobayashi, Kazumichi Abe, Hiromasa Ohira, Hiroaki Haga, Mitsuteru Natsuizaka, Ken Furuya, Satoshi Mochida, Jun Itakura, Masayuki Kurosaki, Atsushi Takahashi, Kenichi Morikawa, Goki Suda, Masami Abe, Masato Nakai, Takuya Sho, Namiki Izumi, Takaaki Izumi
Publikováno v:
Journal of Gastroenterology. 54:641-649
Until recently, interferon-free anti-hepatitis C virus (HCV) therapy for genotype 2 (GT2) HCV-infected hemodialysis patients was an unfulfilled medical need. Recent clinical trials of glecaprevir and pibrentasvir (G/P) for hemodialysis patients showe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca1b43ddd84ec09ea89f0e04a8153f06
https://doi.org/10.1007/s00535-019-01556-y
https://doi.org/10.1007/s00535-019-01556-y
Autor:
Jun Ito, Masato Nakai, Takuya Sho, Toshiya Kamiyama, Goki Suda, Machiko Umemura, Masaru Baba, Katsumi Terasita, Akiyoshi Saga, Ken Furuya, Koji Ogawa, Naoki Kawagishi, Kazuharu Suzuki, Tomofumi Takagi, Takashi Meguro, Kenichi Morikawa, Naoya Sakamoto, Takuto Miyagishima, Akihisa Nakamura, Tomoe Kobayashi, Akinobu Taketomi, Taku Shigesawa, Masatsugu Ohara, Yoshiya Yamamoto, Mitsuteru Natsuizaka
Publikováno v:
Hepatology research : the official journal of the Japan Society of HepatologyReferences. 50(8)
Aim This study aimed to determine the efficacy and safety of lenvatinib for patients with unresectable hepatocellular carcinoma (HCC) who did not meet REFLECT eligibility criteria (phase 3 clinical trial). Methods In this multicenter retrospective st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9db8c3178c7e56f5c894cd788a9a313e
https://pubmed.ncbi.nlm.nih.gov/32562334
https://pubmed.ncbi.nlm.nih.gov/32562334
Autor:
Yoshihito Uchida, Masaru Baba, Katsumi Terasita, Ken Furuya, Kenichi Morikawa, Takuya Sho, Chitomi Hasebe, Satoshi Mochida, Atsuhiko Kawakami, Kazumichi Abe, Machiko Umemura, Goki Suda, Masayuki Kurosaki, Jun Itakura, Atsushi Takahashi, Hiromasa Ohira, Namiki Izumi, Ikuto Masakane, Masato Nakai, Yoshiyuki Ueno, Masami Abe, Tomoe Kobayashi, Koji Ogawa, Naoki Kawagishi, Kenichi Kumagai, Masatsugu Ohara, Mitsuteru Natsuizaka, Naoya Sakamoto, Hiroaki Haga, Yoshiya Yamamoto
Publikováno v:
Journal of Gastroenterology. 54:78-86
The prevalence of hepatitis C virus (HCV) infection in hemodialysis patients is high and results in a poor prognosis. Thus, safer and more effective treatment regimens are required. In this prospective multicenter study, we investigated the efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce5b183592ac489255a98f371f94c5ae
https://doi.org/10.1007/s00535-018-1495-6
https://doi.org/10.1007/s00535-018-1495-6
Autor:
Goki, Suda, Yoshiya, Yamamoto, Astushi, Nagasaka, Ken, Furuya, Mineo, Kudo, Yoshimichi, Chuganji, Yoko, Tsukuda, Seiji, Tsunematsu, Fumiyuki, Sato, Katsumi, Terasita, Masato, Nakai, Hiromasa, Horimoto, Takuya, Sho, Mitsuteru, Natsuizaka, Kouji, Ogawa, Shunsuke, Ohnishi, Makoto, Chuma, Yasuyuki, Fujita, Riichiro, Abe, Miki, Taniguchi, Mina, Nakagawa, Yasuhiro, Asahina, Naoya, Sakamoto
Publikováno v:
Hepatology research. 45(8):837-845
Aim: Telaprevir-based therapy for chronic hepatitis C patients is effective; however, the high prevalence of dermatological reactions is an outstanding issue. The mechanism and characteristics of such adverse reactions are unclear; moreover, predicti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::feda8c75e6c00188503a46569ff3d61c
http://hdl.handle.net/2115/62582
http://hdl.handle.net/2115/62582
Autor:
Yoko Tsukuda, Ken Furuya, Masato Nakai, Yoshimichi Chuganji, Yasuhiro Asahina, Fumiyuki Sato, Astushi Nagasaka, Mitsuteru Natsuizaka, Shunsuke Ohnishi, Takuya Sho, Seiji Tsunematsu, Goki Suda, Hiromasa Horimoto, Miki Taniguchi, Yoshiya Yamamoto, Riichiro Abe, Katsumi Terasita, Naoya Sakamoto, Makoto Chuma, Kouji Ogawa, Mina Nakagawa, Yasuyuki Fujita, Mineo Kudo
Publikováno v:
Hepatology Research. 45:837-845
Aim Telaprevir-based therapy for chronic hepatitis C patients is effective; however, the high prevalence of dermatological reactions is an outstanding issue. The mechanism and characteristics of such adverse reactions are unclear; moreover, predictiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d91db74816e024a02871797dd79c6bd
https://doi.org/10.1111/hepr.12421
https://doi.org/10.1111/hepr.12421